Murray Jason Hulse, the co-founder and CEO of PACS Group, Inc., has reported several stock sales as part of a pre-established trading plan. This activity, documented in a recent SEC filing, highlights Hulse's ongoing management of his equity holdings in the company.
The filing reveals that on October 6 and 7, 2026, Hulse sold a total of 36,692 shares of PACS Group, Inc. The sales were executed at prices ranging from approximately $42.48 to $43.79 per share. These transactions were made under a Rule 10b5-1 trading plan, which allows executives to sell shares at predetermined times to avoid accusations of insider trading.
Background
PACS Group, Inc. operates in the skilled nursing care facilities sector, classified under the SIC code 8051. The company is incorporated in Delaware and has its business address in Salt Lake City, Utah. Hulse is not only the CEO but also serves as the Chairman of the company, holding significant influence over its strategic direction.
What the Filing Says
The SEC filing, dated October 7, 2026, indicates that Hulse sold 28,753 shares on October 6, followed by 7,222 shares on the same day, and an additional 717 shares on October 7. After these transactions, Hulse retains ownership of 54,435,249 shares. The filing notes that the sales were executed under a trading plan established on May 18, 2026.
Impact
These transactions may have implications for PACS Group, Inc. and its stakeholders, including investors and employees. Hulse's actions could signal confidence in the company's future or a personal strategy to diversify his investments. The skilled nursing care facilities industry may also see similar executive behaviors as leaders navigate their financial portfolios amidst changing market conditions.
What's Next
The filing does not say what happens next.